CaltechAUTHORS
  A Caltech Library Service

Natural products as inspiration for the development of asymmetric catalysis

Mohr, Justin T. and Krout, Michael R. and Stoltz, Brian M. (2008) Natural products as inspiration for the development of asymmetric catalysis. Nature, 455 (7211). pp. 323-332. ISSN 0028-0836. PMCID PMC2562237. https://resolver.caltech.edu/CaltechAUTHORS:MOHnat08

[img] PDF - Accepted Version
See Usage Policy.

880Kb

Use this Persistent URL to link to this item: https://resolver.caltech.edu/CaltechAUTHORS:MOHnat08

Abstract

Biologically active natural products often contain particularly challenging structural features and functionalities in terms of synthesis. Perhaps the greatest difficulties are those caused by issues of stereochemistry. A useful strategy for synthesizing such molecules is to devise methods of bond formation that provide opportunities for using enantioselective catalysis. In using this tactic, the desire for a particular target structure ultimately drives the development of catalytic methods. New enantioselective catalytic methods contribute to a greater fundamental understanding of how bonds can be constructed and lead to valuable synthetic technologies that are useful for a variety of applications.


Item Type:Article
Related URLs:
URLURL TypeDescription
http://dx.doi.org/10.1038/nature07370DOIArticle
http://www.nature.com/nature/journal/v455/n7211/abs/nature07370.htmlPublisherArticle
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2562237/PubMed CentralArticle
http://rdcu.be/phPLPublisherFree ReadCube access
ORCID:
AuthorORCID
Mohr, Justin T.0000-0002-7005-3322
Stoltz, Brian M.0000-0001-9837-1528
Additional Information:© 2008 Nature Publishing Group. We thank the National Institute of General Medical Sciences (grant number R01GM080269-01), Eli Lilly (which provided predoctoral fellowships to J.T.M. and M.R.K.), Amgen, Abbott Laboratories, Boehringer Ingelheim, Merck, Bristol–Myers Squibb and the California Institute of Technology for financial support.
Funders:
Funding AgencyGrant Number
NIHR01GM080269-01
Eli LillyUNSPECIFIED
AmgenUNSPECIFIED
Abbott LaboratoriesUNSPECIFIED
Boehringer IngelheimUNSPECIFIED
MerckUNSPECIFIED
Bristol–Myers SquibbUNSPECIFIED
CaltechUNSPECIFIED
Issue or Number:7211
PubMed Central ID:PMC2562237
Record Number:CaltechAUTHORS:MOHnat08
Persistent URL:https://resolver.caltech.edu/CaltechAUTHORS:MOHnat08
Usage Policy:No commercial reproduction, distribution, display or performance rights in this work are provided.
ID Code:13392
Collection:CaltechAUTHORS
Deposited By: Kristin Buxton
Deposited On:16 Jun 2009 15:07
Last Modified:03 Oct 2019 00:37

Repository Staff Only: item control page